Hbsc
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Investigating the Mechanistic Effects of Mitapivat in Subjects With Sickle Cell Disease (NCT05675436) | National Heart, Lung, and Blood Institute (NHLBI) | 2024-05-09 |
Track Hbsc automatically
Every clearance here is in the API, with alerts when new ones post.